— Know what they know.
Not Investment Advice

ASND NASDAQ

Ascendis Pharma A/S
1W: +6.6% 1M: +8.7% 3M: -3.6% YTD: +14.9% 1Y: +22.0% 3Y: +172.6% 5Y: +57.8%
$245.85
+0.70 (+0.29%)
After Hours: $244.00 (-1.85, -0.75%)
Weekly Expected Move ±3.3%
$228 $235 $243 $251 $259
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Buy · Power 73 · $16.1B mcap · 66M float · 1.12% daily turnover · Short 66% of daily vol
Credit Risk of going bust: lower than 83% of companies Debt: 3.0% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.74 (down 99.7%), Ascendis Pharma A/S would be worth roughly what it owes.
Total debt $502.8M against a stock market value of $16.13B.
Distance to default 10.53 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $287.9M (short-term plus half of long-term), stock volatility 38.8%; Altman Z'' 1.93. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Oct Typical
☀️
Sunny
+16.2% YTD avg
Midterm Year
☀️
Sunny
+13.4% YTD avg
2026 Now
☀️
Sunny
Tracking typical
20yr Avg YTD
+16.2%
Day 206 of 252
Midterm Year YTD
+13.4%
Presidential cycle avg
2026 YTD
+15.3%
Below 20yr avg
Typical Vol
38%
Annualized
Monthly Weather Forecast
Jan
20yr
💨
+2.0%
Midterm
☀️
+8.7%
67% win 49% vol
Feb
20yr
💨
+8.2%
Midterm
☀️
+19.2%
58% win 43% vol
Mar
20yr
💨
+12.6%
Midterm
☀️
+18.7%
42% win 86% vol
Apr
20yr
⛈️
+10.9%
Midterm
☀️
+14.6%
42% win 54% vol
May
20yr
⛈️
+10.1%
Midterm
☀️
+21.7%
33% win 48% vol
Jun
20yr
💨
+11.6%
Midterm
☀️
+17.7%
67% win 48% vol
Jul
20yr
🌧️
+11.1%
Midterm
☀️
+17.4%
58% win 33% vol
Aug
20yr
💨
+17.6%
Midterm
☀️
+28.6%
75% win 47% vol
Sep
20yr
💨
+21.5%
Midterm
☀️
+27.1%
58% win 53% vol
Oct
20yr
🌫️
+17.9%
Midterm
☀️
+21.0%
50% win 38% vol
Now: +7.9%
Nov
20yr
💨
+22.2%
Midterm
☀️
+22.1%
82% win 44% vol
Dec
20yr
💨
+4.2%
Midterm
⛈️
-4.0%
55% win 39% vol
Seasonality (20yr)
Updated: 2026-10-27
YTD: +15.3%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms